SCIOS INC
DEFA14A, 2000-01-25
PHARMACEUTICAL PREPARATIONS
Previous: SCIOS INC, DEFA14A, 2000-01-25
Next: LORD ABBETT & CO, SC 13G/A, 2000-01-25




SCHEDULE 14A INFORMATION

                Proxy  Statement  Pursuant  to Section  14(a) of the  Securities
                Exchange Act of 1934 (Amendment No. )

Filed by the Registrant /x/
Filed by a party other than the Registrant / /

Check the appropriate box:
/ / Preliminary Proxy Statement

/ /  Confidential,  for  Use  of the  Commission  Only  (as  permitted  by  Rule
     14a-6(e)(2))
/ / Definitive Proxy Statement
/X/ Definitive  Additional Materials

/ / Soliciting Material Pursuant to Section 240.14a-11(c) or Section
     240.14a-12

                                   Scios Inc.

- --------------------------------------------------------------------------------
                (Name of Registrant as Specified In Its Charter)

- --------------------------------------------------------------------------------
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check the appropriate  box):
/x/ No fee required
/ / Fee computed on table below per Exchange  Act Rules  14a-6(i)(1)
     and 0-11

(1) Title of each class of securities to which transaction applies:

- ------------------------------------------------------------------------

(2) Aggregate number of securities to which transaction applies:

- ------------------------------------------------------------------------

(3) Per unit price or other underlying value of transaction computed pursuant to
Exchange  Act Rule  0-11  (set  forth the  amount  on which  the  filing  fee is
calculated and state how it was determined):

- ------------------------------------------------------------------------

(4) Proposed maximum aggregate value of transaction:

- ------------------------------------------------------------------------

(5) Total fee paid:

- ------------------------------------------------------------------------

/ / Fee paid previously with preliminary materials.

/    / Check box if any part of the fee is offset as provided  by  Exchange  Act
     Rule  0-11(a)(2)  and identify the filing for which the  offsetting fee was
     paid  previously.  Identify the previous filing by  registration  statement
     number, or the Form or Schedule and the date of its filing.

     (1) Amount Previously Paid:

     ------------------------------------------------------------------------

     (2) Form, Schedule or Registration Statement No.:

     ------------------------------------------------------------------------

     (3) Filing Party:

     -----------------------------------------------------------------------

     (4) Date Filed:

     ------------------------------------------------------------------------
<PAGE>

     On January 12, we announced a Company-wide retention program. The following
Q & A has additional information about this program. The full text of the actual
retention   agreements   have  been  filed  with  the  Securities  and  Exchange
Commission,           and          can          be          viewed          here
(http://www.freeedgar.com/search/WL.asp?C=726512&F=8-K&D=1/24/2000).

You can  also  read  additional  information  about  the  program  in our  Proxy
Statement      for     the     February     28,     2000     Annual      Meeting
(http://www.freeedgar.com/search/WL.asp?C=726512&F=DEFC14A&D=1/20/2000).

We have also provided the retention  agreements to Mr. Kirk, per his request. To
see our response to Mr. Kirk, click here (Internet link to document  attached as
Exhibit 99.1 below)

               Q:   What is our retention program?

               A:   Our retention  program is designed to keep employees focused
                    on the business of the company during a time of instability.
                    The Board  decided a  retention  program  was  necessary  to
                    protect the ongoing business  interests of Scios in light of
                    Mr.  Kirk's  proxy  contest to replace the Board.  In recent
                    correspondence,  Mr.  Kirk has  stated  plans  to  eliminate
                    certain functions of Scios, heightening the necessity of the
                    program.

                    This  program  is  important  for  stockholders  because  it
                    stabilizes  the  company's  most  valuable   assets  --  our
                    workforce.

               Q:   Why  does  the  Board  believe  that  the   employees   need
                    protection at this time?

               A:   A proxy contest creates  uncertainty  about the direction of
                    the Company.  And, Mr.  Kirk's stated plans are to eliminate
                    several  functions of Scios.  In light of this  uncertainty,
                    the  Board  felt  employees  needed   protection  for  three
                    reasons.

               o    Job  Security:  As we  anticipated,  Kirk's  ideas for Scios
                    include   eliminating  R&D,   evaluating   management,   and
                    separating  the  Psychiatric  Sales and Marketing  Division.
                    These  statements  create a sense of  insecurity  within the
                    management team and with all employees.

               o    Research & Development:  Kirk's recent letter states that he
                    will eliminate  Scios'  unfunded R&D functions.  This places
                    many highly valued employees in immediate jeopardy of losing
                    their jobs at Scios.  The  proliferation of high-paying jobs
                    in Silicon Valley offers our employees job choices which can
                    impact employee retention,  especially when someone like Mr.
                    Kirk has threatened to eliminate your position.

<PAGE>

               o    Work  Environment  and Career  Opportunity:  We need all our
                    employees  but their  career  prospects  at Scios  have been
                    threatened by this proxy contest.  Many Scios  employees are
                    dedicated  to  discovering  new  therapies  to  advance  the
                    medical  community.  Companies  that Kirk has been  involved
                    with do not  contribute  to the future of  medicine  in this
                    way.  Kirk  has  interests  in a lot  of  private  companies
                    engaged in different kinds of activities.  None appear to be
                    based  on  a  drug  discovery  model.  For  example,   Lotus
                    Biochemical, which Kirk wanted to sell to Scios last summer,
                    is a very different type of company than Scios.

               Q:   How much is this  protection  costing  and what  benefits do
                    employees receive?

               A:   It doesn't have to cost anything.  The retention  program is
                    designed with a "double trigger". This means that two things
                    must  happen  before the  program  costs a dime.  There must
                    first be a change of control  of Scios.  Even after a change
                    of control, nothing happens unless an employee is forced out
                    of the company. Then, and only then, the employee receives a
                    severance  payment.  Employees  fired for cause or who leave
                    voluntarily  without good reason do not receive any benefits
                    under the program.

                    For  information  on the benefits for  employees if a change
                    of control AND involuntary  termination  occurs,  click here
                    (Internet link to chart immediately below).

               Q:   How does this protection help Scios employees?

               A:   The only way Scios  can  continue  to fully and  efficiently
                    implement its aggressive new business plan is to ensure that
                    our employees remain committed to Scios and focused on their
                    jobs without  being  induced to look for a new job in a very
                    competitive job market.

               Q:   Why is this important to stockholders?

               A:   Employee   retention   is  a  key   component   of  building
                    stockholder value.

               Q:   How long does this program continue?

               A:   This  program  will end  December  31,  2001 if a change  of
                    control has not occurred by then, or unless  extended by the
                    Board.  It has been  very  carefully  designed  to  create a
                    stable  job  environment  during  the  next two  years  when
                    programs  for  Natrecor  and a p38 kinase  inhibitor  are in
                    critical phases.

               Q:   How do you respond to Mr. Kirk's  criticism of the retention
                    program?

<PAGE>

               A:   We  believe  that Mr.  Kirk's  attack on the  program is not
                    supported by the facts.

               o    The  Scios  Board,   after   consultation  with  independent
                    compensation  advisors,  instituted  a very  reasonable  and
                    effective  program  to assure  stability  of the Scios  work
                    force during  implementation of the company's aggressive new
                    business plan and time of  instability  because of Kirk. The
                    Board has not dispensed  "multi-year  golden  parachutes" to
                    every employee as Mr. Kirk alleges.

               o    Kirk  suggests the program  raises the question  whether the
                    Scios Board and management hold  stockholder  interests as a
                    priority,  implying  the  program  is  an  act  of  careless
                    disregard of our stockholders' trust. To the contrary, it is
                    precisely   because  Scios   stockholders  are  the  Board's
                    priority that this program has been put in place. Any threat
                    to our workforce is a threat to stockholder value.

<TABLE>
<CAPTION>

                Individual       Flex-Time        Sr ICs           Directors                          Dick Brewer
                Contributors     Sales Force      and              Sr Dirs          VPs               CEO
                                                  Sr Mgrs

<S>            <C>              <C>              <C>              <C>              <C>               <C>
                Level: 0-17                       18-20            21- 24           25+

Seniority       2 wks/yr of      2 wks/yr of      3 wks/yr of      4 wks/yr of      1.5 x Annual      2.25 x Annual
Severance Pay   service          service          service          service          Salary*           Salary*

Minimum         3 months         3 months         3 months         4 months         N/A               N/A
Severance

COBRA -         3 months         3 months         3 months         3 months         18 months         24 months
Medical
Insurance

Out Placement       Yes -            Yes -            Yes -            Yes -            Yes               Yes
Services        Group Wkshops    Group Wkshops    Consultant       Consultant       Consultant        Consultant
                 1 month          1 month          2 months         3 months         6 months          6 months
                Value: $1,800    Value: $1,800    Value: $5,000    Value: $6,500    Value: $10,000    Value: $10,000

<FN>
* including target bonus
</FN>
</TABLE>


January 24, 2000



VIA FACSIMILE AND FEDERAL EXPRESS

Mr. Randal J. Kirk
The Governor Tyler
1902 Downey Street
Radford, VA 24141

         Re:  Scios Inc.

Dear Mr. Kirk:

         Enclosed are the forms of retention agreements recently entered into by
Scios  requested by your  attorney.  The Company has today filed copies of these
agreements with the Securities and Exchange Commission.

         Your  characterization  of  these  retention  agreements  as  providing
"multi-year  golden  parachutes" to all employees is  inaccurate.  The retention
agreements will be in place for two years through  December 31, 2001, to protect
our  employees  during the period when the  programs for Natrecor and p38 kinase
inhibitor  are in critical  phases of  development.  But,  because the retention
agreements have double  triggers,  the program will cost nothing and an employee
will be  entitled  to no  benefits  unless  and until  there is both a change of
control and the employee is forced out of the Company.

         Additionally,  your  characterization  inaccurately  implies  that  all
employees will receive multi-year  severance  payments.  This is not true. As it
effects senior  executives,  the program is clearly and accurately  described in
our proxy statement. As for the rest of our workforce,  the program provides for
lump sum payments and these  employees are entitled to from two to four weeks of
pay for each year of service.  The average  payment  would be equivalent to less
than four months cash compensation for employees below the vice president level.
This  program is similar in scope to the  reduction  in force  program we put in
place at the time our work force was reduced in March of 1999.

<PAGE>

Mr. Randal J. Kirk
January 24, 2000

         In light of the threats to our  employees  in your  announced  plans to
evaluate management,  and more recently to eliminate several functions of Scios,
the Board  believes  it has  instituted,  after  consultation  with  independent
compensation  advisors,  a very  reasonable and effective  program to retain our
valuable  employees  during  implementation  of  the  Company's  aggressive  new
business plan.

Sincerely,

/s/

Donald B. Rice
Chairman of the Board

Enclosure



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission